Cargando…
Parvoviruses-tools to fine-tune anticancer immune responses
Oncolytic virotherapy represents a recent approach to anticancer therapy. Rodent autonomous parvoviruses (PVs) represent naturally oncolytic viruses that are non-pathogenic for humans but possess and extended tropism, being capable of infecting transformed cells of both rodent and human origin. Rece...
Autores principales: | Grekova, Svitlana P., Rommelaere, Jean, Raykov, Zahari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518522/ https://www.ncbi.nlm.nih.gov/pubmed/23243613 http://dx.doi.org/10.4161/onci.21097 |
Ejemplares similares
-
TLR-9 Contributes to the Antiviral Innate Immune Sensing of Rodent Parvoviruses MVMp and H-1PV by Normal Human Immune Cells
por: Raykov, Zahari, et al.
Publicado: (2013) -
Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
por: Li, Junwei, et al.
Publicado: (2013) -
Pancreatic Cancer Cell Lines Can Induce Prostaglandin E2 Production from Human Blood Mononuclear Cells
por: Grekova, Svitlana P., et al.
Publicado: (2011) -
Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responses
por: Wachowska, Malgorzata, et al.
Publicado: (2014) -
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
por: Michaud, Mickaël, et al.
Publicado: (2012)